- Home
- UBX vs ACOG Comparison
UBX vs ACOG Comparison
Compare UBX & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- ACOG
- Stock Information
- Founded
- UBX 2009
- ACOG 2000
- Country
- UBX United States
- ACOG Canada
- Employees
- UBX N/A
- ACOG N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- ACOG
- Sector
- UBX Health Care
- ACOG
- Exchange
- UBX Nasdaq
- ACOG Nasdaq
- Market Cap
- UBX 29.2M
- ACOG 91.6M
- IPO Year
- UBX 2018
- ACOG N/A
- Fundamental
- Price
- UBX $2.22
- ACOG $6.11
- Analyst Decision
- UBX Strong Buy
- ACOG
- Analyst Count
- UBX 2
- ACOG 0
- Target Price
- UBX $7.00
- ACOG N/A
- AVG Volume (30 Days)
- UBX 483.8K
- ACOG 135.6K
- Earning Date
- UBX 11-04-2024
- ACOG 11-15-2024
- Dividend Yield
- UBX N/A
- ACOG N/A
- EPS Growth
- UBX N/A
- ACOG N/A
- EPS
- UBX N/A
- ACOG N/A
- Revenue
- UBX N/A
- ACOG N/A
- Revenue This Year
- UBX N/A
- ACOG N/A
- Revenue Next Year
- UBX $33.62
- ACOG N/A
- P/E Ratio
- UBX N/A
- ACOG N/A
- Revenue Growth
- UBX N/A
- ACOG N/A
- 52 Week Low
- UBX $0.94
- ACOG $4.66
- 52 Week High
- UBX $3.10
- ACOG $7.00
- Technical
- Relative Strength Index (RSI)
- UBX 61.12
- ACOG N/A
- Support Level
- UBX $2.02
- ACOG N/A
- Resistance Level
- UBX $2.42
- ACOG N/A
- Average True Range (ATR)
- UBX 0.31
- ACOG 0.00
- MACD
- UBX 0.01
- ACOG 0.00
- Stochastic Oscillator
- UBX 39.61
- ACOG 0.00
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.